AMED Preclinical tau PET study

JRCT ID: jRCTs051190065

Registered date:23/10/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Preclinical AD, Mild Cognitive Impairment (MCI)
• Date of first enrollment: 23/10/2019
• Target sample size: 40
• Study type: Interventional
• Intervention(s): PET scan using an unapproved PET drug

Outcome(s)

• Primary Outcome: Tau PET

Key inclusion & exclusion criteria

• Age minimum: >= 60age old
• Age maximum: < 85age old
• Gender: Both

Include criteria

1.Subjects who are enrolled in the AMED Preclinical study
2.Informed consent to participate in this tau PET study
3.Able to undergo the tau PET scan within 2 years from the baseline visit of the AMED Preclinical study

Exclude criteria

1.Subjects who should not undergo the tau PET scan as judged by the physician in charge.
2.Subjects who will not be able to complete the tau PET scan

Related Information

• Primary Sponsor: Shimada Hiroyuki
• Source(s) of Monetary Support: Fidelity Foundation,Alzheimer Association,Japan Agency for Medical Research and Development